According to a recent study, gastric cancer cells suppress CD8 T-cell metabolism via CD155/TIGIT signaling, which blocks CD8 T-cell effector activities, leading to hyporesponsive anti-tumor immune reaction [71]. This evidence concerns the gene CD8A and neoplasm.